A phase II trial of Sativex in patients with spasticity due to cerebral palsy
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Nabiximols (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 05 Dec 2016 According to a GW Pharmaceuticals media release, data from the study is expected in the first quarter of 2017.
- 05 Dec 2016 Status changed from active, no longer recruiting to completed, as reported in a GW Pharmaceuticals media release.
- 10 Aug 2016 According to a GW Pharmaceuticals media release, status changed from recruiting to active, no longer recruiting.